Rapid Diagnostics Market Size to Surpass USD 280.03 Bn by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Rapid Diagnostics Market

5.1. COVID-19 Landscape: Rapid Diagnostics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Rapid Diagnostics Market, By Product Type

8.1. Rapid Diagnostics Market, by Product Type

8.1.1. Consumables

8.1.1.1. Market Revenue and Forecast

8.1.2. Instruments/Devices

8.1.2.1. Market Revenue and Forecast

8.1.3. Software & Mobile Apps

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Rapid Diagnostics Market, By Technology

9.1. Rapid Diagnostics Market, by Technology

9.1.1. Lateral Flow Assays (LFA)

9.1.1.1. Market Revenue and Forecast

9.1.2. Agglutination Assays

9.1.2.1. Market Revenue and Forecast

9.1.3. Immunoassays

9.1.3.1. Market Revenue and Forecast

9.1.4. Solid-phase Assays

9.1.4.1. Market Revenue and Forecast

9.1.5. Molecular Diagnostics

9.1.5.1. Market Revenue and Forecast

9.1.5. Isothermal Nucleic Acid Amplification

9.1.6.1. Market Revenue and Forecast

9.1.6. PCR-based Rapid Testing

9.1.7.1. Market Revenue and Forecast

9.1.7. Microfluidics

9.1.8.1. Market Revenue and Forecast

9.1.8. Biosensors

Chapter 10. Global Rapid Diagnostics Market, By Application

10.1. Rapid Diagnostics Market, by Application

10.1.1. Infectious Diseases

10.1.1.1. Market Revenue and Forecast

10.1.2. Cardiology

10.1.2.1. Market Revenue and Forecast

10.1.3. Oncology

10.1.3.1. Market Revenue and Forecast

10.1.4. Diabetes

10.1.4.1. Market Revenue and Forecast

10.1.5. Pregnancy & Fertility

10.1.5.1. Market Revenue and Forecast

10.1.5. Drug of Abuse Testing

10.1.6.1. Market Revenue and Forecast

10.1.6. Blood Glucose Testing

10.1.7.1. Market Revenue and Forecast

10.1.7. Other Chronic Conditions

Chapter 11. Global Rapid Diagnostics Market, By End User

11.1. Rapid Diagnostics Market, by End User

11.1.1. Hospitals & Clinics

11.1.1.1. Market Revenue and Forecast

11.1.2. Home Care Settings

11.1.2.1. Market Revenue and Forecast

11.1.3. Diagnostic Laboratories

11.1.3.1. Market Revenue and Forecast

11.1.4. Pharmacies & Retail Clinics

11.1.4.1. Market Revenue and Forecast

11.1.5. Others (Ambulatory Surgical Centers, Veterinary Clinics, Academic & Research Institutes)

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Rapid Diagnostics Market, By Mode of Testing

12.1. Rapid Diagnostics Market, by Mode of Testing

12.1.1. Professional Testing

12.1.1.1. Market Revenue and Forecast

12.1.2. Self-Testing / Over-the-Counter (OTC)

12.1.2.1. Market Revenue and Forecast

Chapter 13. Global Rapid Diagnostics Market, By Distribution Channel

13.1. Rapid Diagnostics Market, by Distribution Channel

13.1.1. Direct Sales

13.1.1.1. Market Revenue and Forecast

13.1.2. Retail Pharmacies

13.1.2.1. Market Revenue and Forecast

13.1.3. E-commerce Platforms

13.1.3.1. Market Revenue and Forecast

13.1.4. Hospital Pharmacies

13.1.4.1. Market Revenue and Forecast

13.1.5. Wholesalers/Distributors

13.1.5.1. Market Revenue and Forecast

Chapter 14. Global Rapid Diagnostics Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product Type

14.1.2. Market Revenue and Forecast, by Technology

14.1.3. Market Revenue and Forecast, by Application

14.1.4. Market Revenue and Forecast, by End User

14.1.5. Market Revenue and Forecast, by Mode of Testing

14.1.6. Market Revenue and Forecast, by Distribution Channel

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product Type

14.1.7.2. Market Revenue and Forecast, by Technology

14.1.7.3. Market Revenue and Forecast, by Application

14.1.7.4. Market Revenue and Forecast, by End User

14.1.8. Market Revenue and Forecast, by Mode of Testing

14.1.8.1. Market Revenue and Forecast, by Distribution Channel

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product Type

14.1.9.2. Market Revenue and Forecast, by Technology

14.1.9.3. Market Revenue and Forecast, by Application

14.1.9.4. Market Revenue and Forecast, by End User

14.1.10. Market Revenue and Forecast, by Mode of Testing

14.1.11. Market Revenue and Forecast, by Distribution Channel

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product Type

14.2.2. Market Revenue and Forecast, by Technology

14.2.3. Market Revenue and Forecast, by Application

14.2.4. Market Revenue and Forecast, by End User

14.2.5. Market Revenue and Forecast, by Mode of Testing

14.2.6. Market Revenue and Forecast, by Distribution Channel

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product Type

14.2.8.2. Market Revenue and Forecast, by Technology

14.2.8.3. Market Revenue and Forecast, by Application

14.2.9. Market Revenue and Forecast, by End User

14.2.10. Market Revenue and Forecast, by Mode of Testing

14.2.10.1. Market Revenue and Forecast, by Distribution Channel

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product Type

14.2.11.2. Market Revenue and Forecast, by Technology

14.2.11.3. Market Revenue and Forecast, by Application

14.2.12. Market Revenue and Forecast, by End User

14.2.13. Market Revenue and Forecast, by Mode of Testing

14.2.14. Market Revenue and Forecast, by Distribution Channel

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product Type

14.2.15.2. Market Revenue and Forecast, by Technology

14.2.15.3. Market Revenue and Forecast, by Application

14.2.15.4. Market Revenue and Forecast, by End User

14.2.16. Market Revenue and Forecast, by Mode of Testing

14.2.16.1. Market Revenue and Forecast, by Distribution Channel

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product Type

14.2.17.2. Market Revenue and Forecast, by Technology

14.2.17.3. Market Revenue and Forecast, by Application

14.2.17.4. Market Revenue and Forecast, by End User

14.2.18. Market Revenue and Forecast, by Mode of Testing

14.2.18.1. Market Revenue and Forecast, by Distribution Channel

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product Type

14.3.2. Market Revenue and Forecast, by Technology

14.3.3. Market Revenue and Forecast, by Application

14.3.4. Market Revenue and Forecast, by End User

14.3.5. Market Revenue and Forecast, by Mode of Testing

14.3.6. Market Revenue and Forecast, by Distribution Channel

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product Type

14.3.7.2. Market Revenue and Forecast, by Technology

14.3.7.3. Market Revenue and Forecast, by Application

14.3.7.4. Market Revenue and Forecast, by End User

14.3.8. Market Revenue and Forecast, by Mode of Testing

14.3.9. Market Revenue and Forecast, by Distribution Channel

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product Type

14.3.10.2. Market Revenue and Forecast, by Technology

14.3.10.3. Market Revenue and Forecast, by Application

14.3.10.4. Market Revenue and Forecast, by End User

14.3.11. Market Revenue and Forecast, by Mode of Testing

14.3.11.1. Market Revenue and Forecast, by Distribution Channel

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product Type

14.3.12.2. Market Revenue and Forecast, by Technology

14.3.12.3. Market Revenue and Forecast, by Application

14.3.12.4. Market Revenue and Forecast, by End User

14.3.12.5. Market Revenue and Forecast, by Mode of Testing

14.3.12.6. Market Revenue and Forecast, by Distribution Channel

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product Type

14.3.13.2. Market Revenue and Forecast, by Technology

14.3.13.3. Market Revenue and Forecast, by Application

14.3.13.4. Market Revenue and Forecast, by End User

14.3.13.5. Market Revenue and Forecast, by Mode of Testing

14.3.13.6. Market Revenue and Forecast, by Distribution Channel

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product Type

14.4.2. Market Revenue and Forecast, by Technology

14.4.3. Market Revenue and Forecast, by Application

14.4.4. Market Revenue and Forecast, by End User

14.4.5. Market Revenue and Forecast, by Mode of Testing

14.4.6. Market Revenue and Forecast, by Distribution Channel

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product Type

14.4.7.2. Market Revenue and Forecast, by Technology

14.4.7.3. Market Revenue and Forecast, by Application

14.4.7.4. Market Revenue and Forecast, by End User

14.4.8. Market Revenue and Forecast, by Mode of Testing

14.4.9. Market Revenue and Forecast, by Distribution Channel

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product Type

14.4.10.2. Market Revenue and Forecast, by Technology

14.4.10.3. Market Revenue and Forecast, by Application

14.4.10.4. Market Revenue and Forecast, by End User

14.4.11. Market Revenue and Forecast, by Mode of Testing

14.4.12. Market Revenue and Forecast, by Distribution Channel

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product Type

14.4.13.2. Market Revenue and Forecast, by Technology

14.4.13.3. Market Revenue and Forecast, by Application

14.4.13.4. Market Revenue and Forecast, by End User

14.4.13.5. Market Revenue and Forecast, by Mode of Testing

14.4.13.6. Market Revenue and Forecast, by Distribution Channel

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product Type

14.4.14.2. Market Revenue and Forecast, by Technology

14.4.14.3. Market Revenue and Forecast, by Application

14.4.14.4. Market Revenue and Forecast, by End User

14.4.14.5. Market Revenue and Forecast, by Mode of Testing

14.4.14.6. Market Revenue and Forecast, by Distribution Channel

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product Type

14.5.2. Market Revenue and Forecast, by Technology

14.5.3. Market Revenue and Forecast, by Application

14.5.4. Market Revenue and Forecast, by End User

14.5.5. Market Revenue and Forecast, by Mode of Testing

14.5.6. Market Revenue and Forecast, by Distribution Channel

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product Type

14.5.7.2. Market Revenue and Forecast, by Technology

14.5.7.3. Market Revenue and Forecast, by Application

14.5.7.4. Market Revenue and Forecast, by End User

14.5.8. Market Revenue and Forecast, by Mode of Testing

14.5.8.1. Market Revenue and Forecast, by Distribution Channel

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product Type

14.5.9.2. Market Revenue and Forecast, by Technology

14.5.9.3. Market Revenue and Forecast, by Application

14.5.9.4. Market Revenue and Forecast, by End User

14.5.9.5. Market Revenue and Forecast, by Mode of Testing

14.5.9.6. Market Revenue and Forecast, by Distribution Channel

Chapter 15. Company Profiles

15.1. ACON Laboratories, Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Abbott Laboratories

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Artron Laboratories Inc.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Alfa Scientific Designs, Inc.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Becton, Dickinson, and Company

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. BTNX, Inc.

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. bioMérieux SA

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Cardinal Health

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Bio-Rad Laboratories, Inc.

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Danaher Corporation

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global rapid diagnostics market size was reached at USD 42.32 billion in 2024 and it is expected to rake around USD 280.03 billion by 2034.

The global rapid diagnostics market is expected to drive growth at a CAGR of 20.80% from 2025 to 2034.

The major players operating in the rapid diagnostics market are ACON Laboratories, Inc., Abbott Laboratories, Artron Laboratories Inc., Alfa Scientific Designs, Inc., Becton, Dickinson, and Company, BTNX, Inc., bioMérieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., Danaher Corporation, Creative Diagnostics

The market for rapid diagnostics is set to pick up speed before long inferable from the rising need and mindfulness concerning the fast clinical assessment of constant sicknesses, developing interest for point of care (POC) diagnostics, a high convergence of convenient fast testing gadgets on the lookout, ascend in the number of irresistible infection cases, and extending geriatric populace base.

North America region will lead the global rapid diagnostics market over the forecast period 2025 to 2034.